Caxton Associates (New York)’s Neurogene NGNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-808	Closed	-$78K	–	612
2021 Q4	$78K	Buy	+808	New	+$78K	0.01%	509
2020 Q3	–	Sell	-1,060	Closed	-$352K	–	438
2020 Q2	$352K	Buy	+1,060	New	+$352K	0.03%	195